95 related articles for article (PubMed ID: 2126949)
1. Use of revertant cell lines to identify targets of v-fos transformation-specific alterations in gene expression.
Hoemann CD; Zarbl H
Cell Growth Differ; 1990 Dec; 1(12):581-90. PubMed ID: 2126949
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of the junB proto-oncogene is essential for v-fos induced transformation of Rat-1 cells.
Van Amsterdam JR; Wang Y; Sullivan RC; Zarbl H
Oncogene; 1994 Oct; 9(10):2969-76. PubMed ID: 8084600
[TBL] [Abstract][Full Text] [Related]
3. Effect of decreased fte-1 gene expression on protein synthesis, cell growth, and transformation.
Kho CJ; Wang Y; Zarbl H
Cell Growth Differ; 1996 Sep; 7(9):1157-66. PubMed ID: 8877097
[TBL] [Abstract][Full Text] [Related]
4. Transformation of T lymphocytes by the v-fos oncogene.
Valge-Archer VE; de Villiers J; Sinskey AJ; Rao A
J Immunol; 1990 Dec; 145(12):4355-64. PubMed ID: 2124241
[TBL] [Abstract][Full Text] [Related]
5. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
6. Characterization of type II and type XI collagen synthesis by an immortalized rat chondrocyte cell line (IRC) having a low level of type II collagen mRNA expression.
Oxford JT; Doege KJ; Horton WE; Morris NP
Exp Cell Res; 1994 Jul; 213(1):28-36. PubMed ID: 8020600
[TBL] [Abstract][Full Text] [Related]
7. Fos-transformation activates genes associated with invasion.
Hennigan RF; Hawker KL; Ozanne BW
Oncogene; 1994 Dec; 9(12):3591-600. PubMed ID: 7970719
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic modulation of keratins, vimentin, and alpha-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation.
Bisgaard HC; Ton PT; Nagy P; Thorgeirsson SS
J Cell Physiol; 1994 Jun; 159(3):485-94. PubMed ID: 7514612
[TBL] [Abstract][Full Text] [Related]
9. Correlation of collagen synthesis and procollagen messenger RNA levels with transformation in rat embryo fibroblasts.
Sandmeyer S; Smith R; Kiehn D; Bornstein P
Cancer Res; 1981 Mar; 41(3):830-8. PubMed ID: 6257385
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of genes encoding microfilament-associated proteins during Fos-induced morphological transformation.
Jooss KU; Müller R
Oncogene; 1995 Feb; 10(3):603-8. PubMed ID: 7845686
[TBL] [Abstract][Full Text] [Related]
12. Anisomycin abrogates repression of protooncogene c-fos transcription in E1A + cHa-ras-transformed cells through activation of MEK/ERK kinase cascade.
Kukushkin AN; Svetlikova SB; Amanzholov RA; Pospelov VA
J Cell Biochem; 2008 Feb; 103(3):1005-12. PubMed ID: 17647273
[TBL] [Abstract][Full Text] [Related]
13. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
Su ZZ; Yemul S; Stein CA; Fisher PB
Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
15. Type I procollagen synthesis is regulated by steroids and related hormones in human osteosarcoma cells.
Mahonen A; Jukkola A; Risteli L; Risteli J; Mäenpää PH
J Cell Biochem; 1998 Feb; 68(2):151-63. PubMed ID: 9443071
[TBL] [Abstract][Full Text] [Related]
16. Activated fos oncogene in rat embryo fibroblasts transformed by ras and myc oncogenes.
Denner J; Jandrig B; Spitkovsky DD; Ehm I; Kisselyov FL; Schramm T
Neoplasma; 1988; 35(3):263-70. PubMed ID: 3405335
[TBL] [Abstract][Full Text] [Related]
17. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
Topol LZ; Marx M; Calothy G; Blair DG
Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
[TBL] [Abstract][Full Text] [Related]
18. v-FBR-fos oncogene fails to rescue mammalian cells from growth arrest but affects the responses of human fibroblasts to heparin.
Kolettas E; Evangelou A; Gonos ES
Anticancer Res; 2001; 21(1A):435-44. PubMed ID: 11299775
[TBL] [Abstract][Full Text] [Related]
19. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product.
Vallone D; Battista S; Pierantoni GM; Fedele M; Casalino L; Santoro M; Viglietto G; Fusco A; Verde P
EMBO J; 1997 Sep; 16(17):5310-21. PubMed ID: 9311991
[TBL] [Abstract][Full Text] [Related]
20. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
